PHP131 How Can Pharma Industry Prepare Itself for the Changing Pricing and Reimbursement Landscape of Orphan Drugs in EU?
Nov 1, 2011, 00:00 AM
10.1016/j.jval.2011.08.682
https://www.valueinhealthjournal.com/article/S1098-3015(11)02244-3/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
652
First Page :
A357
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02244-3&doi=10.1016/j.jval.2011.08.682